James F. Young is Director at NOVAVAX INC (NVAX). They have made 17 open-market trades across 2 companies since 2006, most recently 2024-12-31.
CIK 0001219864
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
5 open-market purchases totalling $871K since 2011, against 12 sales. Across 5 scored buys the stock is up 23.3% at ninety days, and 21.5 points ahead of the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 20% | 20% | 20% |
| Avg Move | -16.2% | +12.8% | +23.3% |
| Alpha | -11.0% | +12.8% | +21.5% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NVAX | SELL | 2024-12-24 | 2025-01-02 | $8.22 | $82K | -0.2% | -1.6% | -30.2% |
| NVAX | SELL | 2024-06-21 | 2024-06-25 | $14.09 | $106K | -12.6% | +20.8% | -7.2% |
| NVAX | SELL | 2024-06-18 | 2024-06-21 | $13.67 | $190K | -10.5% | +6.6% | -10.7% |
| NVAX | SELL | 2022-03-31 | 2022-04-04 | $73.57 | $1.8M | -21.4% | -15.8% | -13.7% |
| NVAX | SELL | 2021-12-31 | 2022-01-04 | $144.16 | $541K | -19.1% | -35.4% | -45.0% |
| NVAX | SELL | 2021-03-23 | 2021-03-25 | $228.22 | $4.6M | -7.4% | +19.4% | +3.6% |
| NVAX | SELL | 2020-12-31 | 2021-01-05 | $113.09 | $1.2M | +10.3% | +143.2% | +53.5% |
| NVAX | BUY | 2020-06-03 | 2020-06-05 | $48.83 | $73K | +24.3% | +78.2% | +130.8% |
| NVAX | SELL | 2017-08-31 | 2017-09-01 | $1.06 | $186K | +3.6% | +5.4% | +22.5% |
| NVAX | SELL | 2017-03-14 | 2017-03-16 | $1.39 | $139K | -4.4% | -34.6% | -20.7% |
| NVAX | SELL | 2015-06-18 | 2015-06-22 | $9.47 | $474K | -26.3% | -3.5% | -3.5% |
| NVAX | BUY | 2014-03-25 | 2014-03-25 | $4.47 | $112K | -26.3% | -3.5% | -3.5% |
| NVAX | BUY | 2013-06-06 | 2013-06-10 | $1.91 | $191K | -26.3% | -3.5% | -3.5% |
| NVAX | BUY | 2013-03-11 | 2013-03-12 | $2.03 | $203K | -26.3% | -3.5% | -3.5% |
| NVAX | BUY | 2011-12-01 | 2011-12-06 | $1.46 | $292K | -26.3% | -3.5% | -3.5% |
| MEDI | SELL | 2006-11-14 | 2006-11-16 | $32.10 | $139K | N/A | N/A | N/A |
| MEDI | SELL | 2006-02-03 | 2006-02-07 | $32.62 | $282K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.